1Stamey TA, Yang N, Hay AR, et al. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med, 1987, 317: 909-916.
2Mitka M. Is PSA testing still useful? JAMA, 2004, 292:2326-2327.
3Stamey TA, Caldwell M, McNeal JE, et al. The prostate specific antigen era in the United States is over for prostate cancer:what happened in the last 20 years? J Urol, 2004, 172:1297-1301.
4Sakr WA, Grignon DJ, Haas GP, et al. Age and racial distribution of prostatic intraepithelial neoplasia. Eur Urol, 1996,30: 138-144.
5Rich AR. On the frequency of occurrence of occult carcinoma of the prostate. J Urol, 1935,33: 215.
6McNaughton Collins M, Ransohoff DF, Barry MJ. Early detection of prostate cancer. Serendipity strikes again. JAMA,1997, 278: 1516-1519.
7Punglia RS, DAmico AV, Catalona WJ, et al. Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen. N Engl J Med, 2003, 349: 335-342.
3Greenlee RT, Murray T ,Thun M, et al. Cancer statistics, CA Cancer J Clin, 2001,51:15 -36.
4Jemal A, Tiwari R, Murray T, et al. Cancer statistics, CA Cancer J Clin, 2004,54( 1 ) :8229.
5Wilding G . The importance of stefiod hormones in prostate cancer.Cancer Surv, 1992,14 : 113.
6Ross RK ,Paganini - Hill A ,Henderson BE. The etiology of prostate cancer. What does the epidemiology suggest? Prostate,1983,4(4) :333.
7Watkins WS, Bamshad M, Jord LB. Population genetics of trinudeo tide repeat polymorphisms. Hum Mol Genet, 1995,4 ( 10 ) : 1485 -1491.
8Brown, C J, Goss SJ, Lubahn DB, et al. Androgen receptor locus on the human X chromosome: regional localization to Xqll -12 and description of a DNA polymorphism, Am J Hum Genet, 1989,44:264- 269.
9Huang SP,Chou YH,Chang WS,et al. Androgen receptor gene polymorphism and prostate cancer in Taiwan. J Formos Med Assoc,2003,102(10) :680 -686.
10Mishra D,Thangaraj K,Mandhani A,et al. Is reduced CAG repeat length in androgen receptor gene associated with risk of prostate cancer in Indian population? Clin Genet,2005,68 (1) :55 -60.
